(Q42206815)

English

Continuous vincristine infusion as part of a high dose chemoradiotherapy regimen: drug kinetics and toxicity

scientific article published on January 1988

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Continuous vincristine infusion as part of a high dose chemoradiotherapy regimen: drug kinetics and toxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

chemoradiotherapy

0 references

author name string

C R Pinkerton

1

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

B McDermott

2

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

T Philip

3

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

P Biron

4

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

C Ardiet

5

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

H Vandenberg

6

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

M Brunat-Mentigny

7

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

publication date

1 January 1988

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

271-274

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Hepatotoxicity following vincristine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of vincristine infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vincristine treatment of advanced cancer: a cooperative study of 392 cases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vincristine infusion with advanced, relapsed tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioimmunoassay of vinblastine and vincristine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Seizures associated with vincristine sulfate therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overdosage with vincristine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous vincristine infusion: Phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Life-threatening neuropathy and hepatotoxicity in infants during induction therapy for acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can severe vincristine neurotoxicity be prevented?

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous bone marrow transplantation in paediatric solid tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single agent vincristine by infusion in refractory multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/3044635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00273423

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42206815&oldid=2205120242"